Shanghai Bio-Heart Biological Technology Co., Ltd. Class H ( (HK:2185) ) has provided an announcement.
Shanghai Bio-Heart Biological Technology Co., Ltd. successfully conducted its Extraordinary General Meeting and Class Meetings, passing all proposed resolutions. This includes a major transaction involving the deemed disposal of equity interest in a subsidiary and amendments to the company’s articles of association, reflecting strategic shifts and governance updates that may influence its operational and market strategy.
More about Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
Shanghai Bio-Heart Biological Technology Co., Ltd. operates in the biotechnology sector, focusing on the development and commercialization of medical technologies and solutions. The company is primarily engaged in producing cardiovascular devices, aiming to enhance heart health and treatment outcomes.
YTD Price Performance: 5.49%
Average Trading Volume: 47,626
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$724.1M
For an in-depth examination of 2185 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com